Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Pulse Biosciences CS (PLSE)

17.7 -0.68 (-3.7%)

04-23 16:00

Open:

18.51

Pre. Close:

18.38

High:

18.51

Low:

17.1

Volume:

147,184

Market Cap:

299M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

18.53 - 18.681

18.681 - 18.783

Low:

16.804 - 16.961

16.961 - 17.067

Close:

17.488 - 17.739

17.739 - 17.907

Technical analysis  (as of: 2018-04-23 4:32:21 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 26.28     One year: 30.70

Support:

Support1: 16.34    Support2: 12.53

Resistance:

Resistance1: 22.50    Resistance2: 26.28

Pivot:

18.07

Moving Averages:

MA(5): 18.75     MA(20): 16.90

MA(100): 19.81     MA(250): 22.93

MACD:

MACD(12,26): 0.67     Signal(12,26,9): 0.49

%K %D:

%K(14,3): 53.98     %D(3): 61.12

RSI:

RSI(14): 51.23

52-Week:

High: 39.5  Low: 9.811  Change(%): -29.1

Average Vol(K):

3-Month: 16274  10-Days 27500

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
PLSE has closed above bottom band by 43.6%. Bollinger Bands are 22.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-04-18T16:00:00-04:00
Pulse Biosciences Grants Equity Incentive Awards to New Employee

2018-04-17T02:14:33-04:00
Biotech Analysis Central Pharma News: GlaxoSmithKline Passes Along Pipeline, Pulse Impresses, Celldex's Failure

2018-04-16T08:00:00-04:00
Your Daily Pharma Scoop: Intercept's OCA, MediciNova In NASH, Pulse Biosciences Data

2018-04-13T12:52:34-04:00
Midday Gainers / Losers (04/13/2018)

2018-04-13T09:18:25-04:00
Premarket Gainers as of 9:05 am (04/13/2018)

2018-04-13T08:30:52-04:00
Pulse Bio's NPS technology shows positive effect in eliminating skin growths; shares up 13% premarket

2018-04-12T17:19:00-04:00
Pulse Biosciences Announces Positive Results from Its First Study Evaluating a Clinical Target at Major Scientific Meeting

2018-04-05T12:43:55-04:00
Midday Gainers / Losers (4/5/2018)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Advanced Medical Equipment Technology

Shares Out. (M)

16.87

Shares Float (M)

10.54

% Held by Insiders

38.80

% Held by Institutions

14.80

Shares Short (K)

2016

Shares Short Prior Month (K)

1770

Stock Financials

EPS

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

6.940

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-67.2

Return on Equity (ttm)

-71.7

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-11.09

Levered Free Cash Flow (M)

-5.70

atoplab.com

Valuation

P/E

P/E Growth Ratio

P/BV

2.55

P/S

P/CF

-26.92

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.